Ikarian Capital’s Molecular Templates, Inc. MTEM Stock Holding History

Ikarian Capital’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,727	Closed	-$572K	–	186
2019 Q4	$572K	Buy	+2,727	New	+$392K	0.09%	90

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Ikarian Capital's MTEM Position: Q1 2020 in Review

Ikarian Capital sold out of Molecular Templates, Inc. (MTEM) in Q1 2020, closing a stake of 2,727 shares — an estimated $572K sold.

Ikarian Capital first reported a position in MTEM in Q4 2019 and held it in 1 quarter. The position peaked at $572K in Q4 2019. 89 funds tracked by Wall St. Rank hold MTEM as of Q1 2020.

Ikarian Capital reported no remaining Molecular Templates, Inc. position as of Q1 2020 after selling out during the quarter.
Ikarian Capital sold 2,727 Molecular Templates, Inc. shares in Q1 2020, an estimated $572K.
Ikarian Capital first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 1 quarter.
Ikarian Capital's Molecular Templates, Inc. position peaked at $572K in Q4 2019.
89 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2020.

Based on Ikarian Capital's 13F filing for Q1 2020, filed 15 May 2020.